Am J Transplant, Volume 5, Suppl 3 Archives - Page 132 of 170 - ATC Abstracts

2015 American Transplant Congress
Are AT1R Antibodies as Dangerous as HLA-DSAs in Renal Allografts?
E. Cuevas, J. Arreola-Guerra, E. Hernandez-Mendez, I. Salcedo, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Ramirez, D. de Rungs, J. Granados, L. Morales-Buenrostro, J. Alberu.
1Transplantation, 1aNephrology-Mineral Metabolism, Inst Nal de Ciencias Medicas y Nutricion SZ, Mexico City, Distrito Federal, Mexico.
Angiotensin II type 1 receptor antibodies (AT1Rab) have been associated with a significantly lower graft survival and a higher risk of acute rejection after kidney…
2015 American Transplant Congress
Repeat Donor HLA Mismatch Antigens and Kidney Transplant Outcome
P. Lokhandwala,¹ M. Wang,² Z. Kadry,³ R. Shah,³ A. Jain,³ J. Gaspari,¹ N. Ghahramani,⁴ C. Abendroth,¹ H. Shike.¹
¹Pathology, Penn State Hershey Medical Center, Hershey, PA; ²Public Health Sciences, Penn State College of Medicine, Hershey; ³Transplant Surgery, PSHMC, Hershey; ⁴Nephrology, PSHMC, Hershey.
Background: Historically, poorer outcome has been reported in kidney re-transplant patients with repeat HLA mismatch antigens. Transplant practice has evolved. Risk of repeat mismatch antigen…
2015 American Transplant Congress
Impact of Pre-Transplant Panel Reactive Antibody Levels On Renal Graft Survival in Patients With Negative Cross-Match and No Donor Specific Antibody
K. Jun,¹ M. Kim,¹ H. Kim,¹ K. Park,² S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ S. Kim,¹ J. Kim,¹ I. Moon.¹
¹Vascular and Transplant Surgery, The Catholic University of Korea, Seoul, Korea; ²Vascular Surgery, Inha University, Incheon, Korea.
Purposes: This study was conducted to investigate the impact of pre-transplant PRA level on rejection and graft survival after kidney transplantation in patients with negative…
2015 American Transplant Congress
Outcomes in Kidney Transplant Recipients Over Age of 55 by Donor Source: LD, SCD, ECD
V. Kirchner, K. Gillingham, A. Matas, The Div of Tx and Tx Nephrology.
University of Minnesota, Mpls.
Background: Outcomes in older kidney transplant recipients from SCD and ECD have been studied; however, comparative outcomes between older recipients of LD, SCD and ECD…
2015 American Transplant Congress
Infections After Alemtuzumab Induction: A Non Issue?
A. Smith, M. John, I. Dortonne, A. Paramesh, M. Killackey, R. Zhang, B. Lee, J. Buell.
Transplant Institute, Tulane University, New Orleans, LA.
Background: Alemtuzumab is a powerful induction agent that depletes multiple lymphocyte cell lines resulting in leukopenia and/or neutropenia with concerns over infectious complications. This study…
2015 American Transplant Congress
Effect of Everolimus Versus Tacrolimus On Left Ventricular Hypertrophy in Renal Transplant Patients On Maintenance
J. Morales,¹ J. Pascual,² A. Sánchez-Fructuoso,³ D. Serón,⁴ J. Díaz,⁵ F. Oppenheimer,⁶ M. Rengel,⁷ D. Hernández,⁸ J. Cruzado,⁹ On Behalf of Evita Study Group.
¹Fund. Investigación, H. 12 Octubre, Madrid, Spain; ²S. Nefrología, H. del Mar, Barcelona, Spain; ³S. Nefrología, H. Clínico San Carlos, Madrid, Spain; ⁴S. Nefrología, H. Vall Hebrón, Barcelona, Spain; ⁵S. Nefrología, Fund. Puigvert, Barcelona, Spain; ⁶Unidad Trasp. Renal, H. Clínic i Provincial Barcelona, Barcelona, Spain; ⁷S. Urología, H. Gregorio Marañón, Madrid, Spain; ⁸S. Nefrología, H. Carlos Haya, Málaga, Spain; ⁹S. Nefrología, H. Bellvitge. IDIBELL, Barcelona, Spain.
PURPOSE: To compare the efficacy of everolimus (EVL) in improving LVH in a regimen with mycophenolic acid (MPA) vs tacrolimus (TAC)+MPA in maintenance renal transplant…
2015 American Transplant Congress
Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation
A. Weick,¹ K. George,¹ S.-M. Jafri,² D. Moonka.²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI; ²Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI.
Purpose: Evaluate outcomes of sofosbuvir-based hepatitis C therapy in liver transplant patients in a single center clinical setting, including interferon-free regimens.Methods: All patients with history…
2015 American Transplant Congress
Clinical Utility of Allospecific CD154+T-Cells in Children With Liver Or Intestine Transplantation (LTx, ITx)
K. Soltys, G. Bond, G. Mazariegos, C. Ashokkumar, K. Dirling, L. O'Toole, P. Kachmar, T. Hartle, D. Martin, C. Trautz, R. Sindhi.
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
Background: Allospecific CD154+T-cytotoxic memory (CD154+TcM) have completed investigational evaluation as predictors of acute cellular rejection in children with LTx or ITx.Purpose: To evaluate CD154+TcM** as…
2015 American Transplant Congress
Declaring a Patient Brain Dead on Extracorporeal Membrane Oxygenation (ECMO): Are There Guidelines or Misconceptions?
K. Kreitler,¹ N. Cavarocchi,¹ H. Hirose,¹ S. West,² R. Hasz,² M. Ghobrial,³ R. Bell.³
¹Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA; ²Gift of Life Donor Program, Philadelphia, PA; ³Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA.
Purpose: With the rapid growth of ECMO and the accumulating evidence that organs from ECMO donors can be safely transplanted, we reviewed the practice variations…
2015 American Transplant Congress
Primary and Secondary Vaccine Responses in a Non-Human Primate Model of Cardiac Allotransplantation
S. Dahi,¹ E. Kang,¹ T. Zhang,¹ B. Vanhove,² A. Azimzadeh,¹ R. Pierson III.¹
¹Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; ²INSERM, Nantes, France.
Purpose: To compare the effect of calcineurin- versus costimulation-based immunosuppression on primary and secondary vaccine responses in non-human primate heart transplant recipients.Background: Antibody response following…